Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2024-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '솔고바이오메디칼' (Solco Biomedical) covering the period from January 1, 2024, to June 30, 2024. It contains comprehensive financial statements, management discussion and analysis, and detailed business information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. It details changes in share ownership, specifically the addition of joint holders due to voting rights delegation agreements. This type of filing is a standard regulatory requirement for significant shareholding notifications (often referred to as the 5% rule filing in Korea). Based on the provided categories, 'Major Shareholding Notification' (MRQ) is the most accurate classification.
2024-08-07 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) held on 2024-08-05. It details the resolutions passed, specifically capital reduction and changes to the articles of incorporation. According to the provided definitions, the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category is specifically for official results from shareholder votes at any general meeting (AGM or EGM).
2024-08-05 Korean
상호변경안내
AGM Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's name (from Solco Biomedical to Alphanox). It details the change, the reason, and the date of the shareholder meeting where this was approved. Since this is a general regulatory announcement regarding corporate identity that does not fit into specific categories like financial reports, dividends, or director dealings, it is classified as a general regulatory filing.
2024-08-05 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a 'Solicitation of Proxy' (의결권대리행사권유참고서류). It details specific amendments to a previously filed proxy solicitation document, including changes to the proxy solicitor's special relations, the proxy agent, and proposed amendments to the Articles of Incorporation (such as company name change and capital reduction). This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote at an upcoming meeting.
2024-07-31 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Reference Document), which is a standard regulatory filing in South Korea used by companies to request shareholder proxies for upcoming general meetings. It contains specific details regarding the meeting agenda, such as capital reduction (감자) and amendments to the articles of incorporation (정관의 변경). This document is a formal proxy solicitation statement provided to shareholders to inform their voting decisions, which aligns perfectly with the 'Proxy Solicitation & Information Statement' category.
2024-07-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.